Denali Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 775 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 1-25 of 775 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-90223

SCHEDULE 13G/A filing

Filing date
08 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Jun 2026
Reporting date
03 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90223

SCHEDULE 13G filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90223

SCHEDULE 13G/A filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A

Filing date
21 Apr 2026
Reporting date
10 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38311

DEFA14A ADDITIONAL MATERIALS

Filing date
21 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38311

ARS

Filing date
21 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38311

DEF 14A

Filing date
21 Apr 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
3

FORM 3

Filing date
20 Apr 2026
Reporting date
10 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-90223

SCHEDULE 13G/A filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .